Identification of inhibitors for RND efflux pump of Pseudomonas aeruginosa using structure-based pharmacophore modeling approach

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 6, Issue 1, 2014, Pages 84-89

  Aparna, Vasudevan ^a   Mohanalakshmi, Narasumani ^b   Dineshkumar, Kesavan ^a   Hopper, Waheeta ^a  

^a SRM INSTITUTE OF SCIENCE AND TECHNOLOGY   (India)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

110; E pharmacophore; Efflux pumps; Glide; MC 207; Prime; Pseudomonas aeruginosa

Indexed keywords

ASN 04193664; ASN 04194191; ASN 05107178; ASN 05108137; ASN 05303275; DOCKING PROTEIN; EFFLUX PUMP INHIBITOR; LIGAND; MEXB PROTEIN; PHENYLALANYLARGININE 2 NAPHTHYLAMIDE; PROTEIN INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; DRUG DESIGN; MOLECULAR DOCKING; MOLECULAR MODEL; MULTIDRUG RESISTANCE; PHARMACOPHORE; PROTEIN DATABASE; PSEUDOMONAS AERUGINOSA;

EID: 84891928337     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Arunagiri K, Aparna V, Menaka K, Sekar B. Characterization of ESBLs and ISECP1 insertion sequences from Klebsiella pneumoniae and Escherichia coli in a tertiary hospital in India. Int J Phar Pharm Sci 2013; 5(3):654-658.
2. Li XZ, Zhang L, Poole K. Interplay between the MexA-MexB-OprM multidrug efflux system and the outer membrane barrier in the multiple antibiotic resistance of Pseudomonas aeruginosa. J Antimicrob Chemother 2000; 45(4):433-6.
3. Sennhauser G, Bukowska MA, Briand C, Grütter MG. Crystal structure of the multidrug exporter MexB from Pseudomonas aeruginosa. J Mol Biol 2009; 389(1):134-45.
4. Masuda N, Sakagawa E, Ohya S, Gotoh N, Tsujimoto H, Nishino T. Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXY-OprM efflux pumps in Pseudomonas aeruginosa. Antimicrob Agents Chemother 2000; 44(12):3322-7.
5. Guan L, Ehrmann M, Yoneyama H, Nakae T. Membrane topology of the xenobiotic-exporting subunit, MexB, of the MexAB-OprM extrusion pump in Pseudomonas aeruginosa. J Biol Chem 1999; 274(15):10517-22.
6. Lin J, Martinez A. Effect of efflux pump inhibitors on bile resistance and in vivo colonization of Campylobacter jejuni. J Antimicrob Chemother 2006; 58(5):966-72.
7. Lomovskaya O, Watkins W. Inhibition of efflux pumps as a novel approach to combat drug resistance in bacteria. J Mol Microbiol Biotechnol 2001; 3(2):225-36.
8. Salam NK, Nuti R, Sherman W. Novel method for generating structure-based pharmacophores using energetic analysis. J Chem Inf Model 2009; 49(10):2356-68.
9. Suenaga A, Okimoto N, Hirano Y, Fukui K. An efficient computational method for calculating ligand binding affinities. PLoS ONE 2012; 7(8): e42846.
10. Chen L, Li Y, Yu H, Zhang L, Hou T. Computational models for predicting substrates or inhibitors of P-glycoprotein. Drug Discov Today 2012; 17(7-8):343-51.
11. Dupree T. Pharmacophore development and validation for inhibitors of the bacterial NorA efflux pump, M. Sc., Department of Chemistry, University of Wollongong, 2005.